Atıf İçin Kopyala
ÖZTÜRK N., KARA A., VURAL İ.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.17, sa.5, ss.492-499, 2020 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
17
Sayı:
5
-
Basım Tarihi:
2020
-
Doi Numarası:
10.4274/tjps.galenos.2019.76402
-
Dergi Adı:
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, International Pharmaceutical Abstracts, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.492-499
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Objectives: Telmisartan (TLM) is an antihypertensive drug that has been shown to have antiproliferative effects on cancer cells. It has low solubility and suboptimal oral bioavailability. To investigate the potential anticancer effect of TLM on breast cancer cells, poly (D, L-lactide) (PLA) nanoparticles were formulated with the benefit of improving its solubility.